In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Cardiovascular Devices, Who's Next?

Executive Summary

Whereas much of the activity in cardiovascular M&A in the past seems to have come from a euphoric sense of the promise of cardiovascular medicine, the more recent moves have an air of frustrated hopes. The two large deals announced most recently, Boston Scientific Corp.'s acquisition of Pfizer Inc.'s Schneider angioplasty business and Medtronic Inc.'s purchase of external defibrillator company Physio-Control International corp. seem to have been driven by sellers looking for exit strategies as much as buyers looking for new opportunities.

Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts